483
Avanti Polar LipidsFDA 483 - Avanti Polar Lipids - July 07, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
During an inspection from July 5-7, 2023, Avanti Polar Lipids, an excipient manufacturer in Alabaster, AL, was cited for inadequate controls over computer systems. The firm's data integrity Standard Operating Procedures (SOPs) were found deficient, specifically lacking proper management of chromatography audit trails and user privileges, indicating significant concerns with data reliability.
Open in Dashboard
ID · 463261f3-8aad-4200-af6b-15f1939ba298